We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Cytotoxic Lymphocytes Fight Stomach Cancer

By LabMedica International staff writers
Posted on 15 Jul 2010
Cells in the immune system that react to stomach cancer bacterium have been identified.

Helicobacter pylori are Gram-negative, microaerophilic bacteria that can inhabit various areas of the stomach, particularly the antrum. More...
It is one of the most common bacterial infections in the world, and leads to chronic inflammation of the stomach.

These bacteria cause a chronic low-level rubor of the stomach lining, and are strongly linked to the development of duodenal and gastric ulcers and stomach cancer. As the symptoms of stomach carcinomas are varied, they are often discovered at a late stage and have a very poor prognosis. Over 80% of individuals infected with H. pylori are generally symptom-free.

Natural killer (NK) cells, a type of immune cell, can both recognize and kill cells that are infected by viruses and bacteria as well as tumor cells. They kill cells by releasing small cytoplasmic granules of proteins called perforin and granzyme that cause the target cell to die by apoptosis.

A team of scientists at the University of Gothenburg (Gothenburg, Sweden) examined how NK cells reacted to H. pylori. They found that a special type of NK cells was active against the stomach ulcer bacterium and the NK cells produced cytokines, which are the immune system's signal substances and act as a defense against the intruder.

Gastric or stomach cancer is a malignant tumor in the mucous membrane of the stomach, and is one of the more common forms of cancer in Sweden. There are about 24,000 new cases of this disease diagnosed annually in the USA.

Asa Lindgren, Ph.D., who wrote her doctoral thesis on the subject, suggests that NK cells can play an important role in the immune defense against H. pylori. Previously it was shown that a high proportion of NK cells in tumor tissue have contributed to a better prognosis and longer survival for patients with stomach cancer, as these cells help to eliminate the tumor cells.

Related Links:
University of Gothenburg




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.